
KPV Oral 100 × 500mcg Immunity
Tablet format · needle-freeOral anti-inflammatory.
The alpha-MSH tripeptide goes oral. Its small size gives it an oral bioavailability most peptides will never reach: gut, skin and joint inflammatory models, with no injection. 100 pre-dosed 500mcg tablets, HPLC ≥ 98%. EU stock.
Research Use Only (RUO) · Prohibited for human or veterinary use.
Key facts
Protocol and preparation
Asepsis
Disinfect surfaces and stoppers (70% alcohol).
Solvent
Draw the required volume of bacteriostatic water.
Introduction
Inject gently against the vial wall (avoid direct jet on powder).
Solubilization
Roll the vial gently. Do not shake vigorously (degradation risk).
Solution storage Once reconstituted: 2-8°C (refrigerator).
Warning Theoretical tool for chemical handling. Does not constitute medical advice.
Open the dilution calculator- The vial carries no individual label. That is our standard packaging, not a downgraded vial.
- The parcel is plain. Nothing on the outside indicates the contents or the brand name.
What is not normal: a cracked vial, an uncrimped cap or a stopper that moves, powder that has liquefied or changed colour. In those specific cases, write to us with a photo and we take the vial back.
Technical data
- Reconstitution
- Comprimés pré-dosés, aucune reconstitution.
- Peptide sequence
- Lys-Pro-Val
- Molecular formula
- C16H30N4O4
- Molecular weight
- 342.43 g/mol
- CAS number
- 67727-97-3
- Physical form
- Comprimés oraux
- Recommended solubility
- Formulation orale pré-dosée — pas de reconstitution nécessaire
- Storage conditions
- Température ambiante, à l'abri de la lumière et de l'humidité
- Use
- Research reagent, in vitro only (RUO)
Frequently asked questions
What is the purity of KPV Oral?
How should KPV Oral be stored?
How do I reconstitute KPV Oral 100 × 500mcg?
Is a certificate of analysis (COA) available?
Is KPV Oral intended for human consumption?
What are the research applications of KPV Oral?
The complete guideKPV peptide: complete guide to the anti-inflammatory α-MSH tripeptideKPV (Lys-Pro-Val), the 11-13 fragment of α-MSH: NF-κB blockade, gut uptake via PepT1, colitis studies, colon-targeted nanoparticles, skin data, oral vs injectable KPV, dosage in studies, reconstitution and status. No human trial published.Read the guide Also read:Oral peptides in research: bioavailability changes the game
